title: Unexpected pancytopenia following treatment of acute lymphoblastic leukemia.
authors.affiliation: Department of Haematology, Imperial College Healthcare NHS Trust, Hammersmith Hospital, Du Cane Road, London W12 0HS.
authors.forename: Andrew
authors.initials: A
authors.lastname: Innes
authors.forename: Philippa C
authors.initials: PC
authors.lastname: May
authors.forename: Jiří
authors.initials: J
authors.lastname: Pavlů
authors.forename: Barbara J
authors.initials: BJ
authors.lastname: Bain
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000009:adverse effects* / Q000627:therapeutic use; D001853:Bone Marrow / Q000473:pathology*; D002896:Chromosomes, Human, Pair 6 / Q000648:ultrastructure; D002899:Chromosomes, Human, Pair 9 / Q000648:ultrastructure; D003131:Combined Modality Therapy; D016371:Cranial Irradiation; D003561:Cytarabine / Q000008:administration & dosage; D003630:Daunorubicin / Q000008:administration & dosage / Q000009:adverse effects*; D004920:Erythropoiesis / Q000187:drug effects; D005047:Etoposide / Q000008:administration & dosage / Q000009:adverse effects*; D005260:Female; D006801:Humans; D015470:Leukemia, Myeloid, Acute / Q000139:chemically induced* / Q000175:diagnosis / Q000235:genetics; D060046:Maintenance Chemotherapy / Q000009:adverse effects; D015122:Mercaptopurine / Q000008:administration & dosage; D008727:Methotrexate / Q000008:administration & dosage / Q000009:adverse effects; D008875:Middle Aged; D016609:Neoplasms, Second Primary / Q000139:chemically induced* / Q000175:diagnosis / Q000235:genetics; D015514:Oncogene Proteins, Fusion / Q000235:genetics; D010198:Pancytopenia / Q000139:chemically induced* / Q000473:pathology; D015452:Precursor B-Cell Lymphoblastic Leukemia-Lymphoma / Q000188:drug therapy* / Q000532:radiotherapy; D014178:Translocation, Genetic; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D015514:Oncogene Proteins, Fusion; D003561:Cytarabine; D014750:Vincristine; D005047:Etoposide; D015122:Mercaptopurine; D008727:Methotrexate; D003630:Daunorubicin